Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive preclinical results of SB-939 in hematological cancer models

Dec. 24, 2007

FDA issues nonapprovable letter for Indevus' Valstar

Dec. 21, 2007

Cytopia initiates phase II trial of anticancer vascular-disrupting agent CYT-997

Dec. 21, 2007

Oxford Genome Sciences and Amgen enter collaboration for therapeutic antibodies in cancer

Dec. 21, 2007

Single-agent activity seen with perifosine in malignant gliomas

Dec. 21, 2007

Kiadis Pharma successfully completes end of phase II meeting with FDA for Reviroc

Dec. 20, 2007

Idera and Merck KGaA collaborate on development of TLR9 agonists for cancer

Dec. 20, 2007

Actelion reports preliminary data from bosentan proof-of-concept cancer study

Dec. 20, 2007

GlaxoSmithKline exercises option to further develop and commercialize Exelixis' XL-880

Dec. 20, 2007

T cells expressing costimulatory ligands, a novel approach in cancer immunotherapy

Dec. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026